Article
Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and…
bioRxiv: the preprint server for biology · 2020 · Tim Hempel, author LluÃs Raich, author Simon Olsson, author Nurit P. Azouz, author Andrea M. Klingler, author Marc E. Rothenberg, author Frank Noé, author
Key facts
| Title | Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and Nafamostat mesylate |
|---|---|
| First author | Tim Hempel, author LluÃs Raich, author Simon Olsson, author Nurit P. Azouz, author Andrea M. Klingler, author Marc E. Rothenberg, author Frank Noé, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Aug 15, 2020 |
| DOI | 10.1101/2020.07.21.214098 |
| Devices mentioned | 077826 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1